Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Madrigal Pharmaceuticals (MDGL) Asset Utilization Ratio (2019 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Asset Utilization Ratio for 8 consecutive years, with 0.73 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 329.27% to 0.73 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.73, a 329.27% increase, with the full-year FY2025 number at 0.83, up 288.97% from a year prior.
  • Asset Utilization Ratio was 0.73 for Q4 2025 at Madrigal Pharmaceuticals, up from 0.62 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.73 in Q4 2025 to a low of 0.0 in Q2 2021.
  • A 3-year average of 0.27 and a median of 0.17 in 2024 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: crashed 74.72% in 2021, then soared 3719.66% in 2025.
  • Madrigal Pharmaceuticals' Asset Utilization Ratio stood at 0.0 in 2021, then soared by 6497.58% to 0.17 in 2024, then soared by 329.27% to 0.73 in 2025.
  • Per Business Quant, the three most recent readings for MDGL's Asset Utilization Ratio are 0.73 (Q4 2025), 0.62 (Q3 2025), and 0.51 (Q2 2025).